CERo Therapeutics Holdings, Inc. Common Stock (CERO) — Tangible Net Worth Ratio
CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Tangible Net Worth Ratio of 100.0% as of June 2023. This metric is calculated by deducting intangible assets ($0.00) from net assets ($549.25K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CERO book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
CERo Therapeutics Holdings, Inc. Common Stock Tangible Net Worth Ratio (2021–2022)
This chart shows how CERo Therapeutics Holdings, Inc. Common Stock's Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2022. As of June 2023, the ratio stands at 100.0%, reflecting net assets of $549.25K with intangible assets of $0.00 USD. Also explore net asset momentum of CERo Therapeutics Holdings, Inc. Common to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for CERo Therapeutics Holdings, Inc. Common Stock (2021–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for CERo Therapeutics Holdings, Inc. Common Stock from 2021 to 2022, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market cap of CERo Therapeutics Holdings, Inc. Common .
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $2.47 Million | $0.00 | $42.37 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $170.83 Million | $0.00 | $180.08 Million | — |